Contraindicated in patients with history of allergy or anaphylaxis to rabbit proteins, or who have an acute viral illness.
- TRADE NAME: Thymoglobulin (Genzyme)
- INDICATIONS: Immunosuppression in solid organ transplantation
- CLASS: Immunosuppressant
- HALF-LIFE: 2–3 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
